# Effect of Probiotics on Helicobacter Pylori Eradication

> **NCT04034641** · PHASE4 · UNKNOWN · sponsor: **Hangzhou Grand Biologic Pharmaceutical, Inc.** · enrollment: 238 (estimated)

## Conditions studied

- Helicobacter Pylori Eradication

## Interventions

- **DRUG:** Bifidobacterium tetrad live bacteria tablet plus Helicobacter pylori quadruple eradication therapy
- **DRUG:** Bifidobacterium tetrad live bacteria tablet placebo plus Helicobacter pylori quadruple eradication therapy

## Key facts

- **NCT ID:** NCT04034641
- **Lead sponsor:** Hangzhou Grand Biologic Pharmaceutical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-17
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2019-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04034641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04034641, "Effect of Probiotics on Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04034641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*